Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,675,993
+$3,308,046 QoQ
Shares Held
54,889
+61.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#169
of 477 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Sep 30, 2024CallValue
$2,376,000
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. CYTK ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
This page
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in CYTK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,675,993 | 54,889 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,367,947 | 34,037 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $954,065 | 20,282 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,999,166 | 37,863 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $2,376,000 | 45,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $2,709,000 | 50,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $583,247 | 10,765 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,380,185 | 162,319 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $1,023,606 | 14,600 | Call | Sole | 2024-05-14 | |
| 2022-06-30 | $273,851 | 6,970 | Shares | Sole | 2022-08-30 | |
| No filing history on record for this holder in this stock. | ||||||